Vapear podría aumentar las probabilidades de los adolescentes de una COVID grave
VIERNES, 10 de febrero de 2023 (HealthDay News) — Los jóvenes sanos que vapean o fuman quizá se estén poniendo en un mayor riesgo de desarrollar una COVID grave, encuentra una investigación reciente.Tanto fumar como vapear cigarrillos electrónicos po…
Learn MorePaxlovid Remains Potent Against Omicron COVID Cases
MONDAY, Feb. 13, 2023 (HealthDay News) — The COVID-19 antiviral treatment Paxlovid continues to work against Omicron subvariants BA.4 and BA.5, new research shows.Researchers decided to study Paxlovid’s impact against severe illness and death because…
Learn MoreUn nuevo medicamento inyectado podría prevenir la COVID grave
JUEVES, 9 de febrero de 2023 (HealthDay News) — Una sola inyección de un medicamento biológico experimental podría reducir a la mitad el riesgo de hospitalización por una infección con la COVID-19, muestran los resultados de un nuevo ensayo clínico.E…
Learn MoreVaping Could Raise Teens’ Odds for Severe COVID
FRIDAY, Feb. 10, 2023 (HealthDay News) — Healthy young people who vape or smoke may be putting themselves at greater risk for developing severe COVID, new research finds.Both smoking tobacco and vaping electronic cigarettes may predispose people to i…
Learn MoreEl aumento de los casos de COVID en China no ha producido nuevas variantes, según un estudio
MIÉRCOLES, 8 de febrero de 2023 (HealthDay News) — En medio del brote reciente de COVID-19 en China, los científicos afirman que parece que no se han desarrollado nuevas variantes.”Dado el impacto que las variantes han tenido en el curso de la pandem…
Learn MoreNew Injected Drug May Prevent Severe COVID
THURSDAY, Feb. 9, 2023 (HealthDay News) — A single injection of an experimental biologic drug may cut in half your risk of hospitalization from COVID-19 infection, new clinical trial results show.Pegylated lambda interferon (PEG-lambda) proved effect…
Learn MoreRhinoviruses, Enteroviruses Persisted During Pandemic Among Pediatric Patients
WEDNESDAY, Feb. 8, 2023 (HealthDay News) — Rhinoviruses and/or enteroviruses persisted during the pandemic for children and adolescents, according to a study published online Feb. 7 in JAMA Network Open.Danielle A. Rankin, Ph.D., M.P.H., from the Van…
Learn MoreRhinoviruses, Enteroviruses Persisted During Pandemic Among Pediatric Patients
WEDNESDAY, Feb. 8, 2023 (HealthDay News) — Rhinoviruses and/or enteroviruses persisted during the pandemic for children and adolescents, according to a study published online Feb. 7 in JAMA Network Open.Danielle A. Rankin, Ph.D., M.P.H., from the Van…
Learn MoreChina’s Surge in COVID Cases Has Produced No New Variants: Study
WEDNESDAY, Feb. 8, 2023 (HealthDay News) — Amidst the recent COVID-19 outbreak in China, scientists are saying it appears no new variants developed. “Given the impact that variants have had on the course of the pandemic, it was important to investiga…
Learn MoreCOVID-19 Vaccine Protection Lasts at Least Six Months After Second Dose
TUESDAY, Feb. 7, 2023 (HealthDay News) — Vaccine protection against severe outcomes from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) lasts at least six months after the second dose, but protection is lower for older patients, accordi…
Learn More